minimal Common Oncology Data Elements (mCODE) Implementation Guide
4.0.0-ballot - STU4 Ballot United States of America flag

minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions

: cancer-related-medication-request-gefitinib - XML Representation

Raw xml | Download


<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="cancer-related-medication-request-gefitinib"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationRequest cancer-related-medication-request-gefitinib</b></p><a name="cancer-related-medication-request-gefitinib"> </a><a name="hccancer-related-medication-request-gefitinib"> </a><a name="cancer-related-medication-request-gefitinib-en-US"> </a><p><b>Procedure Intent Extension</b>: <span title="Codes:{http://snomed.info/sct 373808002}">Curative - procedure intent</span></p><p><b>Normalization Basis Extension</b>: <span title="Codes:{http://snomed.info/sct 301898006}">Body surface area (observable entity)</span></p><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>medication</b>: <span title="Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 349472}">gefitinib 250 MG Oral Tablet</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-john-anyperson.html">John B. Anyperson  Male, DoB: 1951-01-20 ( Medical Record Number: m123 (use: usual, ))</a></p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-kyle-anydoc.html">Practitioner Kyle Anydoc </a></p><p><b>reasonCode</b>: <span title="Codes:{http://snomed.info/sct 254637007}">Non-small cell lung cancer (disorder)</span></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: 250mg orally once daily with or without food</p><p><b>timing</b>: Code , Events: 2019-04-01 , Once per 1 days</p><p><b>route</b>: <span title="Codes:{http://snomed.info/sct 26643006}">Oral use</span></p><h3>DoseAndRates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Dose[x]</b></td></tr><tr><td style="display: none">*</td><td>250 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg = 'mg')</span></td></tr></table></blockquote></div>
  </text>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="373808002"/>
        <display value="Curative - procedure intent"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="301898006"/>
        <display value="Body surface area (observable entity)"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <status value="active"/>
  <intent value="order"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="349472"/>
      <display value="gefitinib 250 MG Oral Tablet"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/cancer-patient-john-anyperson"/>
  </subject>
  <authoredOn value="2019-04-01"/>
  <requester>🔗 
    <reference value="Practitioner/us-core-practitioner-kyle-anydoc"/>
  </requester>
  <reasonCode>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="254637007"/>
      <display value="Non-small cell lung cancer (disorder)"/>
    </coding>
  </reasonCode>
  <dosageInstruction>
    <text value="250mg orally once daily with or without food"/>
    <timing>
      <event value="2019-04-01"/>
      <repeat>
        <boundsPeriod>
          <start value="2019-04-30"/>
        </boundsPeriod>
        <frequency value="1"/>
        <period value="1"/>
        <periodUnit value="d"/>
      </repeat>
      <code>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/v3-GTSAbbreviation"/>
          <code value="QD"/>
        </coding>
      </code>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="26643006"/>
        <display value="Oral use"/>
      </coding>
    </route>
    <doseAndRate>
      <doseQuantity>
        <value value="250"/>
        <unit value="mg"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg"/>
      </doseQuantity>
    </doseAndRate>
  </dosageInstruction>
</MedicationRequest>